Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Embraces Teva Across Brand-Generic Divide

Executive Summary

PhRMA accepts Teva's request for membership; BIO rejected Teva five years ago.

You may also be interested in...



Teva, Allergan Probably Won't Need More Divestments To Get FTC Approval

Parties have already agreed to sell more than 50 products so far, but are still extending outside date for closing of Teva's acquisition of Allergan's generic business until October.

For Generics Industry, Will Larger Firms Mean Weaker Lobbying?

New CEO Chip Davis wants GPhA sitting at the table in policy debates rather than being on the menu, but industry consolidation means there are fewer dues-paying members to fill the chairs.

Biosimilars Forum: How Do You Create A Brand-Generic Coalition? Don’t Talk About Naming

Group of 11 companies is focusing on biosimilar reimbursement and educational issues important to market formation.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS118787

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel